Reaction
Gastric Antral Vascular Ectasia reporting signals
As of the last recalculation, Gastric Antral Vascular Ectasia appears in 513 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is IMATINIB (PRR 127.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Imatinib | 50 | 127.3 | 127.7 |
| Dalteparin Sodium | 12 | 47.1 | 47.2 |
| Everolimus Tablets | 18 | 45.1 | 45.1 |
| Imatinib Mesylate | 20 | 30.2 | 30.3 |
| Sorafenib | 15 | 30.2 | 30.2 |
| Rifaximin | 15 | 29.9 | 29.9 |
| Methoxy Polyethylene Glycol-Epoetin Beta | 5 | 18.6 | 18.6 |
| Dasatinib | 12 | 13.4 | 13.4 |
| Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 4 | 5.3 | 5.3 |